Goldman Sachs reports 5.8% stake in GeneDx Holdings
The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC report beneficial ownership of Class A common stock of GENEDX HOLDINGS CORP.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
The Goldman Sachs Group, Inc. and its subsidiary Goldman Sachs & Co. LLC report beneficial ownership of Class A common stock of GENEDX HOLDINGS CORP. They report aggregate beneficial ownership of 1,733,592.38 shares, representing 5.8% of the class.
Both entities report 0 shares with sole voting and dispositive power and 1,733,499.38 shares with shared voting power and 1,733,509.38 shares with shared dispositive power. Ownership is reported by GS Group as a parent holding company, with the securities owned or deemed owned by Goldman Sachs & Co. LLC, a registered broker-dealer and investment adviser. The Goldman Sachs reporting units disclaim beneficial ownership in certain client accounts and investment entities as described.
Key Figures
Key Terms
beneficially owned financial
parent holding company financial
investment adviser financial
disclaim beneficial ownership financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership stake in GENEDX HOLDINGS CORP. (WGS) does Goldman Sachs report?
How much voting power in GENEDX (WGS) does Goldman Sachs report?
Which Goldman Sachs entities are reporting GENEDX (WGS) ownership?
Does Goldman Sachs disclaim any beneficial ownership in its GENEDX (WGS) Schedule 13G?
AI-generated analysis. How Rhea-AI works. Not financial advice.